

QUICK LINKS
Orally active, subtype-selective NR1A/NR2B NMDA receptor antagonist (IC50 values are 5.3, 35000 and > 100000 nM for NR1A/2B, NR1A/2A and NR1A/2C receptor subtypes respectively). Potentiates the effect of L-DOPA in 6-OHDA-lesioned rats following oral administration.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TCS 46b, 10 mg | sc-204328 | 10 mg | $149.00 | |||
TCS 46b, 50 mg | sc-204328A | 50 mg | $630.00 |